Abstract / Description of output

Proton Magnetic Resonance Spectroscopy yields metabolic information and has proved to be a useful addition to structural imaging in neurological diseases. We applied short-echo time Spectroscopic Imaging in a cohort of 42 patients with Secondary Progressive Multiple Sclerosis (SPMS). Linear modelling with respect to brain tissue type yielded metabolite levels that were significantly different in white matter lesions compared with normal appearing white matter, suggestive of higher myelin turnover (higher choline), higher metabolic rate (higher creatine) and increased glial activity (higher myo-inositol) within the lesions. These findings suggest that the lesions have ongoing cellular activity that is not
consistent with the usual assumption of ‘chronic’ lesions in SPMS, and may represent a target for repair therapies.
Original languageEnglish
JournalJournal of Neurology
Early online date30 May 2018
Publication statusE-pub ahead of print - 30 May 2018


Dive into the research topics of 'Characterisation of tissue-type metabolic content in Secondary Progressive Multiple Sclerosis: a Magnetic Resonance Spectroscopic Imaging study'. Together they form a unique fingerprint.

Cite this